MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.01 (0.43%)	0.02 (0.85%)	-0.02 (-0.84%)	0.05 (2.16%)	0.01 (0.43%)	-0.01 (-0.75%)	0.9 (67.67%)	1.03 (77.44%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -26.2222
Diluted P/E:: -26.2222
RSI(14) 1m:: 60.63
VWAP:: 2.35
RVol:: 13.9717

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.0 +0.02 (+1.01%)	Oct 15 16:17
1m	Price increase 1m	2.0 +0.02 (+1.01%)	Oct 15 16:17
1m	Price increase 1m	2.0 +0.02 (+1.01%)	Oct 15 16:17
1m	Price increase 1m	2.0 +0.02 (+1.01%)	Oct 15 16:17
1m	Price increase 1m	2.0 +0.02 (+1.01%)	Oct 15 16:17